Lidocaine Mucilage-ICG as an Optical Agent for Tumor Delineation During Breast-conserving Surgery
NCT04438577
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Lidocaine mucilage-ICG
Sponsor
Shantou Central Hospital